Agree II Cat

DOMAIN 1.
SCOPE AND PURPOSE
!
!
1. The overall objective(s) of the guideline is (are) specifically described.
!
!
1 !4 7
2 3 5 6
Strongly Disagree Strongly Agree
!
!
Comments !
! !
!!
! !
! !
!
!
2. The health question(s) covered by the guideline
! is (are) specifically described.
!
1 ! 7
2 3 !4 5 6
!
!
Comments
! !
! Even defines general terms e.g. what !acute pain is.
! !
! !
!
!
!
3. The population (patients, public, etc.) to whom
!
the guideline is meant to apply is
specifically described. !
!
1 !4 7
2 3 5 6
Strongly Disagree ! Strongly Agree
!
Comments !
! !
! Page VII document/guidelines is written !
for practitioners an clinicans.
! !
! !
!
!
!
!
! !
43"
! !
!
DOMAIN 2. STAKEHOLDER INVOLVEMENT
!
4. The guideline development group includes
! individuals from all relevant professional
groups.
views and preferences have been sought.
!
1 ! 7
2 3 4! 5 6
!
Comments
!
! !
From pharmaicology to chiropractic, has ! all different professional groups
!
! included. !
! !
!
!
5. The views and preferences of the target population (patients, public, etc.) have been
!
sought.
!
!
1 7
2 3 4! 5 6
!
Comments !
!
Made/written for practitioners and clinicians
! .
! !
! !
!
6. The target users of the guideline are clearly
! defined.
!
1 ! 7
2 3 4 5 6
!
Comments !
!
Yes for clinicians and general practitioners.
!
!
!
!
!
!
!
! !
44"
! !
!
DOMAIN 3. RIGOUR OF DEVELOPMENT
!
! !
7. Systematic methods were used to search for evidence.
1 7
2 3 4 5 6
Comments
!
!
!
!
8. The criteria for selecting the evidence are clearly described.
1 7
2 3 4 5 6
Comments
!
! Has levels of evidence provided page VIII
!
!
9. The strengths and limitations of the body of evidence are clearly described.
1 7
2 3 4 5 6
Comments
Under
! many different headings state the different limitations the studies in
!
reviews have faced. E.g. 4.11.3 Adverse effects states limitations. Strengths
!are the positives the many different studies have found and worked.
!
! !
45"
! !
!
DOMAIN 3. RIGOUR OF DEVELOPMENT continued
!
!
10. The methods for formulating the recommendations are clearly described.
!
!
1 7
2 3 4! 5 6
!
!
Comments !
!Example 5.8.5.4 Infection —> Strongest ! recommendation is hand hygiene.
! !
!
Also tells you how to uses the recommendations. In key notes.
!
!!
!
11. The health benefits, side effects, and risks! have been considered in formulating the
recommendations. !
!
1 ! 7
2 3 4! 5 6
!
!
Comments
! Under all different headings example explains ! the risks/side effects and HB
! of all different treatment types. !
! !
!
12. There is an explicit link between the recommendations and the supporting
evidence. !
!
!
1 7
2 3 4! 5 6
!
!
Comments !
!
! All backed up with references from the! reviews that were used etc.
!
! !
! !
!
!
!
!
! !
46"
! !
!
!
!
!
13. The guideline has been externally reviewed by experts prior to its publication.
!
1 ! 7
2 3 4! 5 6 ! Agree
Strongly Disagree Strongly
Comments
!
! Yes, and reviews every 5 years by all different professional streams.
!
!
14. A procedure for updating the guideline is provided.
1 7
2 3 4 5 6
Comments
!
! Appendix B provides the procedure for the updating of the guideline.
!
!
! !
47"
! !
!
DOMAIN 4. CLARITY OF PRESENTATION
!
!
15. The recommendations are specific and unambiguous.
!
!
1 ! 7
2 3 4 5 6
!
Comments !
! !
!
Yes, recommends what should be followed some topics could be explained
!
! in further details !
! !
!
16. The different options for management of! the condition or health issue are clearly
presented. !
!
1 ! 7
2 3 4
! 5 6
!
!
Comments
!
!As above some topics that are covered could have went in to more detail
!
!
about recommendation of treatment ! how to implement them.
and
!
!
!
DOMAIN 5. APPLICABILITY
17. Key recommendations are easily identifiable.
!
1 ! 7
2 3 4 5 6
!
!
Comments !
Yes, at the end of each topic it has key! points that should be recommended
!
! when proceeding treatment plans.
!
!
!
!
!
!
!
!
! !
48"
! !
!
DOMAIN 5. APPLICABILITY
!
!
18. The guideline describes facilitators and barriers
! to its application.
!
1 ! 7
2 3 4 5 6
!
Comments ! !
!
Under some topics of decision the barriers have been described and some
!
!with facilitators are described, example 2.3.12 and 8.1.7 place where to find
!some.
19. The guideline provides advice and/or tools on how the recommendations can be
put into practice.
1 7
2 3 4 5 6
Comments
! Yes it does provided advice but some topics could have some more
! information provided.
!
!
20. The potential resource implications of applying the recommendations have been
considered.
1 7
2 3 4 5 6
Comments
!
! Unsure where this has happened.
!
!
! !
49"
! !
!
DOMAIN 5. APPLICABILITY continued
!
!
21. The guideline presents monitoring and/or auditing criteria.
!
!
1 ! 7
2 3 4 5 6
!
Comments !
! !
Unsure if this is there.
! !
! !
! !
!
!
!
!
!
!
!
!
!
!
!
!
!
DOMAIN 6. EDITORIAL INDEPENDENCE
!
!
!
!
!
!
!
!
!
!
!
!
!
! !
50"
! !
!
DOMAIN 6. EDITORIAL INDEPENDENCE
!
!
22. The views of the funding body have not influenced
! the content of the guideline.
!
1 ! 7
2 3 4 5 6
Comments
! Doesn’t say one thing is the best treatment for all conditions so it doesn’t
! influence content. Plus their was a wide variety of people/professionals
! reviewing
!
23. Competing interests of guideline development group members have been recorded
and addressed.
1 7
2 3 4 5 6
Comments
!
! Yes, under appendix B
!
!
! !
51"
! !
OVERALL GUIDELINE ASSESSMENT
For each question, please choose the response which best characterizes the guideline
assessed:
1. Rate the overall quality of this guideline.
1 7
Lowest possible 2 3 4 5 6 Highest possible
quality quality
2. I would recommend this guideline for use.
Yes
Yes, with modifications
No
NOTES
yes with modifications —> would have more information for low back pain
and musculoskeletal pain
! !
52"
! !

Agree II Cat

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Agree II Cat

Uploaded by

Copyright:

Available Formats

DOMAIN 1.

SCOPE AND PURPOSE

DOMAIN 2. STAKEHOLDER INVOLVEMENT

DOMAIN 3. RIGOUR OF DEVELOPMENT

8. The criteria for selecting the evidence are clearly described.

DOMAIN 3. RIGOUR OF DEVELOPMENT continued

DOMAIN 3. RIGOUR OF DEVELOPMENT continued

14. A procedure for updating the guideline is provided.

DOMAIN 4. CLARITY OF PRESENTATION

DOMAIN 5. APPLICABILITY continued

DOMAIN 6. EDITORIAL INDEPENDENCE

DOMAIN 6. EDITORIAL INDEPENDENCE

1. Rate the overall quality of this guideline.

2. I would recommend this guideline for use.

Yes, with modifications

You might also like